Lorglumide

(Synonyms: CR-1409)

Lorglumide (CR-1409) is an orally active Cholecystokinin Receptor antagonist. Lorglumide inhibits pancreatic cancer cell proliferation, induces G0/G1 phase arrest and apoptosis, and downregulates MMP-2. Lorglumide inhibits gastrin-stimulated Ornithine decarboxylase activity and DNA synthesis, and shows low CCKA/CCKB selectivity. Lorglumide blocks Caerulein (HY-A0190)-induced exocrine pancreatic secretion and pancreatic tissue hyperplastic changes in rats, and inhibits gallbladder emptying induced by exogenous and endogenous CCK in mice. Lorglumide can be used in research related to pancreatic cancer and pancreatic exocrine function.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • No. CAS: 97964-56-2
  • Fòrmula: C22H32Cl2N2O4
  • Peso molecular:459.41
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00